Question 1

Does Lazard Asset Management own SRNE stock?

Accepted Answer

As of its Q4 2022 13F, Lazard Asset Management held 40,229 shares of SRNE (Sorrento Therapeutics), worth $35,000.

Question 2

How many shares of SRNE does Lazard Asset Management own?

Accepted Answer

As of its Q4 2022 13F, Lazard Asset Management held 40,229 shares of SRNE (Sorrento Therapeutics).

Question 3

What is Lazard Asset Management's SRNE position worth?

Accepted Answer

As of its Q4 2022 13F, Lazard Asset Management's SRNE position was worth $35,000.

Question 4

When did Lazard Asset Management first buy SRNE?

Accepted Answer

Lazard Asset Management first reported SRNE in its Q1 2020 13F and listed it in 5 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2023-Q1 Latest	Exited	0	-100.0%	$0	0.0%	$0.37	0
2022-Q4	New	40,229	-	$35,000	0.0%	$0.89	30
2022-Q3	Exited	0	-100.0%	$0	0.0%	$1.58	0
2022-Q2	New	39,498	-	$79,000	0.0%	$1.99	30
2020-Q4	Exited	0	-100.0%	$0	0.0%	$7.24	0
2020-Q3	Decreased	1,787	-93.3%	$19,000	0.0%	$11.60	0
2020-Q2	Decreased	26,596	-8.3%	$167,000	0.0%	$6.11	0
2020-Q1	New	29,009	-	$53,000	0.0%	$1.85	29

SRNE8 quarters

SRNE
8 quarters